Myelodysplastic Syndrome (RAEB-II) Development 2 Months after Chemotherapy for a Primary Non-seminomatous Mediastinal Germ Cell Tumor / 대한내과학회지
Korean Journal of Medicine
;
: 460-463, 2016.
Article
in English
| WPRIM
| ID: wpr-101313
ABSTRACT
Here, we report on a 20-year-old patient with a primary nonseminomatous mediastinal germ cell tumor (MGCT) who developed myelodysplastic syndrome (MDS) 2 months following chemotherapy with cisplatin, etoposide, ifosfamide, and paclitaxel. Bone marrow examinations revealed that the MDS was a refractory anemia with excess type II blasts and complex chromosomal abnormalities. With the onset of MDS occurring rapidly following chemotherapy, it is unlikely to have been caused by the therapy. We discuss the association between primary nonseminomatous MGCTs and hematological malignancies, including the possibility of a common clonal origin.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Bone Marrow Examination
/
Myelodysplastic Syndromes
/
Anemia, Refractory
/
Chromosome Aberrations
/
Cisplatin
/
Paclitaxel
/
Neoplasms, Germ Cell and Embryonal
/
Hematologic Neoplasms
/
Drug Therapy
/
Etoposide
Limits:
Humans
Language:
English
Journal:
Korean Journal of Medicine
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS